Physician profile
James Joyner
NPI 1265526602
$1,044.39
in general payments reported to CMS, 2019-2025
9 companies · $110 in 2025
The $110 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $212 · 2020: $34.89 · 2021: $109 · 2022: $522 · 2023: $55.96 · 2025: $110.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $166.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $166.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Parapro, LLC | $400.00 | 2022 | |
| Glaxosmithkline, LLC. | $343.39 | 2019-2023 | Trelegy Ellipta |
| Takeda Pharmaceuticals U.S.A., INC. | $93.06 | 2019-2020 | |
| Genzyme Corporation | $92.60 | 2025 | |
| Merck Sharp & Dohme LLC | $33.33 | 2019 | |
| Exact Sciences Corporation | $32.36 | 2023 | Cologuard Collection Kit |
| Cipher Pharmaceuticals US LLC | $17.45 | 2025 | Spinosad, Natroba |
| Ferring Pharmaceuticals INC. | $16.38 | 2019 | |
| Abbvie INC. | $15.82 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Joyner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.